Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Compound 4 is a promising treatment for hair loss with low toxicity.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Bicalutamide shows promise for treating female hair loss.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Abatacept may help some people with alopecia areata regrow hair.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Bicalutamide may help treat female pattern hair loss.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

El acetato de ciproterona trata problemas androgénicos como hirsutismo, acné, seborrea y alopecia con diferentes dosis y combinaciones.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Baicalin may effectively treat hair loss by inhibiting 5α-reductase.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Baricitinib improved hair loss and arthritis in a lupus patient.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.